Best education system. Laws that protect women's rights. #1 ranked place to live.

BioNJ announces 2020 Innovator Award honorees

Anthony Vecchione | NJBIZ

In 2019, 50 percent of all new novel FDA drug approvals – 24 out of 48 new molecular entities – came from companies with a footprint in New Jersey.

BioNJ will honor each of these companies with an Innovator Award during its 27th Annual Dinner Meeting & Innovation Celebration on Feb. 6 at the Hilton East Brunswick.

BioNJ’s Annual Dinner Meeting will bring together 700 biotechnology and pharmaceutical professionals, academic leaders, service providers and government officials to celebrate groundbreaking medical innovation coming from the Garden State.

“We are so proud of New Jersey’s robust life sciences ecosystem which is responsible for exactly half of all of the 2019 novel innovations now making their way to patients with cancer, Parkinson’s disease, heart disease, multiple sclerosis and more, reinforcing the fact that the Garden State is the drug development capital of the world,” said BioNJ Chief Executive Officer and President Debbie Hart. “Our members are helping patients live longer, better lives while lessening the burden of illness and disease on society. We are pleased to celebrate their important work and dedication in this way.”

Innovator companies to be included include:

  • Allergan for Ubrelvy
  • Amgen for Evenity
  • Bayer Healthcare for Nubeqa
  • Beigene USA for Brukinsa
  • Bristol-Myers Squibb for Inrebic and Reblozyl
  • Daiichi Sankyo Inc. for Enhertu and Turalio
  • Eisai Inc. for Dayvigo
  • Eli Lilly for Reyvow
  • Galderma Research and Development LLC for Aklief
  • Janssen Biotech for Balversa
  • Jazz Pharma for Sunosi
  • Kyowa Kirin for Nourianz
  • Merck & Co. for Recarbrio
  • Novartis for Adakveo, Beovu, Piqray, Mayzent and Egaten
  • Pfizer for Vyndaqel
  • Sanofi for Cablivi
  • Shionogi & Co. for Fetroja
  • SK Life Science for Xcopri

Read the full article here.

WHAT CAN CHOOSE New Jersey DO FOR YOU

Relocation & Expansion Services

We provide customized RFI responses, demographics, detailed market assessments and other complimentary business relocation and expansion services. When your company chooses to grow in New Jersey, we also will help you publicize your good news.

Site Visits

We’ll make your property search seamless, so you find the site that best meets your relocation or expansion needs.

Economic Development Connections

Our public and private partners provide a wide range of services. From higher education research collaboration to regulatory and legal assistance to workforce training, they’ll ensure you have a smooth landing.

Carly Wronko
Director of Marketing